Sponsor:
Artelus AI
Code:
NCT07222293
Conditions
Diabetic Retinopathy (DR)
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Accepted
Interventions
Fundus Image Grading
Brief summary:
Conditions
Diabetic Retinopathy (DR)
Study ID
NCT07222293
Start date
Nov 23, 2025
Status verified date
Dec, 2025
Completion date
Mar, 2026
Anticipated
Primary completion date
Mar, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Accepted
Enrollment
900 participants
Anticipated
Interventions
Fundus Image Grading
Primary outcome measure
Central contacts
Locations
New Century Ophthalmology - Oxford
Recruiting
Oxford, North Carolina, United States, 27565
Contacts
Principal Investigator:
Vinod Jindal, MD
New Century Ophthalmology - Raleigh
Recruiting
Raleigh, North Carolina, United States, 27617
Contacts
Principal Investigator:
Vinod Jindal, MD
Sponsor
Artelus AI
Last update posted
Dec 9, 2025
Last verified
Dec, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Artelus AI on 2025-12-09.